About RCP Diagnostics
RCP Diagnostics is a Healthcare company based in Phoenix (United States) founded in 2005, and was acquired by Provista Diagnostics in December 2006. Blood-based immunoassays for womens cancers were developed. Its chief executive, as recorded, is William Gartner. The company was acqui-hired. Its focus areas include Life Sciences, Oncology, In-Vitro Diagnostic Tests and Women's Cancer. Its competitors include Mirvie, DotLab and SynapDx; 3 of its 3 listed competitors have raised funding.
Company details
RCP Diagnostics was established in 2005 in Phoenix, United States, within the diagnostics sector. Blood-based immunoassays targeting womens cancers were created, with the primary product being a radioimmunoassay that assessed riboflavin carrier protein levels to indicate breast, ovarian, cervical, and uterine conditions. Operations focused on these diagnostic tools until acquisition by Provista Life Sciences in December 2006.
- Headquarters Phoenix, United States
- Stage Acquired
- SectorsHealthcare
- Website rcpdiagnostics.com
- Acquired by Provista Diagnostics (Dec 2006)
- Investors
- Acquired byProvista Diagnostics
(Dec 2006)
Investors in RCP Diagnostics
RCP Diagnostics has secured backing from 1 investor. Prominent investors backing the company include Provista Diagnostics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Blood-based diagnostic tests for early women's cancer detection are developed. | 2007 | provistadx.com | New York, United States |
Investor details for RCP Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of RCP Diagnostics
1 people are tracked at RCP Diagnostics (1 in leadership).
| Name | Role | Group |
|---|---|---|
William Gartner | CEO | Leadership |
Complete people profiles for RCP Diagnostics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of RCP Diagnostics
2 dated milestones of RCP Diagnostics across 1 years, from founding to its latest funding, stage changes and deals.
- Founded RCP Diagnostics is founded.
- Exit Acquired by Provista Diagnostics.
Competitors of RCP Diagnostics
RCP Diagnostics has 3 listed competitors in our database, 3 of them funded. They include Mirvie, DotLab and SynapDx.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| mirvie.com | 2019 | San Francisco, United States | $113.7M | 35 | Non-invasive blood tests for prenatal fetal health predictions are offered. | |
| dotlab.com | 2016 | Branford, United States | $10M | 11 | Molecular diagnostic testing for endometriosis is provided via saliva-based biomarkers. | |
| synapdx.com | 2010 | Southborough, United States | $32.75M | Online platform offering HGH injections for energy, performance, and anti-aging. |
Detailed competitors of RCP Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Oncology
3 companies that operate in the same segment as RCP Diagnostics (Oncology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about RCP Diagnostics
RCP Diagnostics was founded in 2005.
RCP Diagnostics is headquartered in Phoenix, United States. It is registered at Phoenix, Arizona, United States.
William Gartner is the CEO of RCP Diagnostics, as recorded in our data.
RCP Diagnostics was established in 2005 in Phoenix, United States, within the diagnostics sector. Blood-based immunoassays targeting womens cancers were created, with the primary product being a radioimmunoassay that assessed riboflavin carrier protein levels to indicate breast, ovarian, cervical, and uterine conditions. Operations focused on these diagnostic tools until acquisition by Provista Life Sciences in December 2006.
RCP Diagnostics has 1 investor. Key investors include Provista Diagnostics.
Yes. RCP Diagnostics was acquired by Provista Diagnostics in December 2006.